Abstract
Traditionally, hepatic resection is the first-line treatment option for liver tumors, and the 5-year survival rate is up to 60–80 %. However, because of only partial patients being suitable for surgery and the high recurrence rate, minimally invasive treatment including transcatheter arterial chemoembolization and local thermal ablation techniques develops rapidly these years. Among the measures, radiofrequency ablation and microwave ablation have already been recommended as alternatives for the treatment of liver tumors. However, some researchers hold the view that central tumors close to the hepatic hilum or large vessels are unsuitable for percutaneous thermal ablation because of the risk of injuring adjacent bile ducts, and an important inherent effect of heat-sink from large vessels on thermal ablation may influence the treatment result for these tumors. At present, some researchers have already tried to put radiofrequency ablation into practice for treating liver tumors adjacent to large vessels with satisfying results. As another kind of thermal ablation techniques, microwave ablation has its special features, such as higher intratumoral temperatures, larger ablation zones, less ablation time, and less dependence on the electrical conductivities of tissue. These advantages may make microwave ablation treatment less affected by heat-sink. In this chapter, we will discuss the effectiveness and safety of percutaneous microwave ablation for liver tumors adjacent to large vessels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CEUS:
-
Contrast-enhanced ultrasound
- HCC:
-
Hepatocellular carcinoma
- MWA:
-
Microwave ablation
- RFA:
-
Radiofrequency ablation
- TACE:
-
Transcatheter arterial chemoembolization
References
EASL-EORTC. Clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–43.
Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg. 1995;221(3):291–8.
Lee CS, Sheu JC, Wang M, Hsu HC. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg. 1996;83(3):330–3.
Yamamoto H, Nagino M, Kamiya J, Hayakawa N, Nimura Y. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe. Surgery. 2005;137(1):26–32.
Nakamura S, Suzuki S, Konno H, Baba S. Resection of metastatic liver tumors with special reference to hepatic venous system. Hepatogastroenterology. 1998;45(19):24–8.
Aoki T, Sugawara Y, Imamura H, Seyama Y, Minagawa M, Hasegawa K, Kokudo N, Makuuchi M. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer. J Am Coll Surg. 2004;198(3):366–72.
Hemming AW, Reed AI, Langham MR, Fujita S, van der Werf WJ, Howard RJ. Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg. 2002;235(6):850–8.
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37(2):429–42.
Poggi G, Pozzi E, Riccardi A, Tonini S, Montagna B, Quaretti P, Tagliaferri B, Sottotetti F, Baiardi P, Pagella C, Minoia C, Bernardo G. Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. Anticancer Res. 2010;30(12):5159–64.
Alvarez R, Banares R, Echenagusia A, Carneros JA, Santos L, Simo G, Camunez F. Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma. Gastroenterol Hepatol. 2000;23(4):153–8.
Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep. 2004;11(1):105–9.
Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223(2):331–7.
Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology. 2005;235(1):299–307.
Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z, Zhang J. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol. 2003;180(6):1547–55.
Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia. 2010;26(5):448–55.
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.
Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 2008;47(1):82–9.
McGhana JP, Dodd 3rd GD. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol. 2001;176(1):3–16.
Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol. 2002;178(1):47–51.
Orlacchio A, Bolacchi F, Chegai F, Bergamini A, Costanzo E, Del Giudice C, Angelico M, Simonetti G. Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm. Radiol Med. 2014;119(5):298–308.
Tatli S, Acar M, Tuncali K, Morrison PR, Silverman S. Percutaneous cryoablation techniques and clinical applications. Diagn Interv Radiol. 2010;16(1):90–5.
Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236(1):132–9.
Nan Q, Zheng W, Fan Z, Liu Y, Zeng Y. Analysis to a critical state of thermal field in microwave ablation of liver cancer influenced by large vessels. Int J Hyperthermia. 2010;26(1):34–8.
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210(3):655–61.
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000;214(3):761–8.
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology. 2004;127(6): 1714–23.
Zhou P, Liang P, Yu X, Wang Y, Dong B. Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract. J Gastrointest Surg. 2009;13(2):318–24.
Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, Mine N, Kondo Y, Kawabe T, Omata M. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43(5):1101–8.
Lu DS, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R, Sayre J. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 2003;14(10):1267–74.
Meloni MF, Andreano A, Bovo G, Chiarpotto B, Amabile C, Gelsomino S, Lazzaroni S, Sironi S. Acute portal venous injury after microwave ablation in an in vivo porcine model: a rare possible complication. J Vasc Interv Radiol. 2011;22(7):947–51.
Yu NC, Raman SS, Kim YJ, Lassman C, Chang X, Lu DS. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol. 2008;19(7):1087–92.
Ren H, Liang P, Yu X, Wang Y, Lu T, Li X. Treatment of liver tumours adjacent to hepatic hilum with percutaneous microwave ablation combined with ethanol injection: a pilot study. Int J Hyperthermia. 2011;27(3):249–54.
Huang S, Yu J, Liang P, Yu X, Cheng Z, Han Z, Li Q. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: A long-term follow-up. Eur J Radiol. 2014;83(3):552–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Huang, Sj., Yu, J., Liang, P. (2015). Percutaneous Microwave Ablation for Liver Tumors Adjacent to Large Vessels. In: Liang, P., Yu, Xl., Yu, J. (eds) Microwave Ablation Treatment of Solid Tumors. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9315-5_7
Download citation
DOI: https://doi.org/10.1007/978-94-017-9315-5_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9314-8
Online ISBN: 978-94-017-9315-5
eBook Packages: MedicineMedicine (R0)